ReGen Therapeutics Limited (“RGTL” or “the Company”) announces that it has today issued its Report and Financial Statements for the twelve months to 31st December 2011. A copy of the full Report and Accounts are now downloadable from the Company’s website (www.regentherapeutics.com).
A meeting for shareholders will take place at 10.30am on Monday 22nd October at the offices of Bird and Bird LLP, 15 Fetter Lane, London EC4A 1JP. It is hoped to be able to issue a further trading update as a Shareholder Bulletin prior to the meeting.
The meeting is open to all shareholders of record at that date. Shareholders intending to come to the meeting are requested to confirm as such by sending an e-mail to email@example.com.
ReGen Therapeutics Limited
Tim Shilton, Chief Executive Officer
Norman Lott, Finance Director
+44 20 7153 4920